Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers
- PMID: 20368443
- PMCID: PMC2867701
- DOI: 10.1073/pnas.0913880107
Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers
Abstract
Recent evidence suggests that endothelial dysfunction and pathology of pulmonary vascular responses may serve as a precursor to smoking-associated emphysema. Although it is known that emphysematous destruction leads to vasculature changes, less is known about early regional vascular dysfunction which may contribute to and precede emphysematous changes. We sought to test the hypothesis, via multidetector row CT (MDCT) perfusion imaging, that smokers showing early signs of emphysema susceptibility have a greater heterogeneity in regional perfusion parameters than emphysema-free smokers and persons who had never smoked (NS). Assuming that all smokers have a consistent inflammatory response, increased perfusion heterogeneity in emphysema-susceptible smokers would be consistent with the notion that these subjects may have the inability to block hypoxic vasoconstriction in patchy, small regions of inflammation. Dynamic ECG-gated MDCT perfusion scans with a central bolus injection of contrast were acquired in 17 NS, 12 smokers with normal CT imaging studies (SNI), and 12 smokers with subtle CT findings of centrilobular emphysema (SCE). All subjects had normal spirometry. Quantitative image analysis determined regional perfusion parameters, pulmonary blood flow (PBF), and mean transit time (MTT). Mean and coefficient of variation were calculated, and statistical differences were assessed with one-way ANOVA. MDCT-based MTT and PBF measurements demonstrate globally increased heterogeneity in SCE subjects compared with NS and SNI subjects but demonstrate similarity between NS and SNI subjects. These findings demonstrate a functional lung-imaging measure that provides a more mechanistically oriented phenotype that differentiates smokers with and without evidence of emphysema susceptibility.
Conflict of interest statement
Conflict of interest statement: E.A.H. and G. M. are founders and shareholders of VIDA Diagnostics, a company commercializing lung-imaging software derived from laboratory research.
Figures
Comment in
-
Preclinical vascular disease identifies smokers at risk for COPD.Proc Natl Acad Sci U S A. 2010 May 11;107(19):8503-4. doi: 10.1073/pnas.1003826107. Epub 2010 May 4. Proc Natl Acad Sci U S A. 2010. PMID: 20442330 Free PMC article. No abstract available.
References
-
- Hoffman EA, et al. Characterization of the interstitial lung diseases via density-based and texture-based analysis of computed tomography images of lung structure and function. Acad Radiol. 2003;10:1104–1118. - PubMed
-
- Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000;343:269–280. - PubMed
-
- Rabe KF, et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
